Pyoderma gangrenosum, acne and suppurative hidradenitis syndrome following bowel bypass surgery

Dermatology. 2012;225(3):215-9. doi: 10.1159/000343602. Epub 2012 Nov 16.

Abstract

The clinical triad of pyoderma gangrenosum (PG), acne and suppurative hidradenitis (PASH) has recently been described as a new disease entity within the spectrum of autoinflammatory syndromes, which are an emerging group of inflammatory diseases distinct from autoimmune, allergic and infectious disorders. PASH syndrome is similar to PAPA (pyogenic arthritis, acne and PG), but it differs in lacking the associated arthritis and on a genetic basis. PAPA syndrome is caused by mutations in a gene involved in the regulation of innate immune responses, the PSTPIP1, while no mutations have been detected to date in patients with PASH syndrome. We report a young male patient who developed coexisting disseminated PG, typical suppurative hidradenitis and acneiform eruption on the face, after he had undergone bowel bypass surgery for obesity. The cutaneous manifestations associated with bowel bypass syndrome often mimic PG or other neutrophilic dermatoses, suggesting a pathogenesis related to neutrophil-mediated inflammation for this condition. This is the first report describing PASH syndrome after bariatric surgery, and we propose to include such neutrophilic dermatoses in the list of complications occurring after bowel bypass surgery. Extensive genetic studies may help to clarify the etiopathogenesis of PASH as well as of autoinflammatory diseases in general.

Publication types

  • Case Reports

MeSH terms

  • Acne Vulgaris / etiology*
  • Acne Vulgaris / pathology
  • Adult
  • Autoimmune Diseases / etiology*
  • Autoimmune Diseases / pathology
  • Gastric Bypass / adverse effects*
  • Hidradenitis Suppurativa / etiology*
  • Hidradenitis Suppurativa / pathology
  • Humans
  • Male
  • Obesity / surgery
  • Postoperative Complications
  • Pyoderma Gangrenosum / etiology*
  • Pyoderma Gangrenosum / pathology
  • Tumor Necrosis Factor-alpha / adverse effects
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Tumor Necrosis Factor-alpha